US5340828A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Inhibitors of farnesyl protein transferase
Assignee: Merck and Co Inc
•
Filing: 1991-09-30
•
Granted: 1994-08-23
•
Expires: 2011-09-30
Abstract
Abstract The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.
Inventors
- 👤 Samuel L. Graham
- 👤 S. Jane deSolms
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 12:43
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06008; C07K5/06017; C07K5/06034; A; A61; A61P; A61P35/00; C07K5/08; C07K5/0802; C07K5/0804; C07K5/0808; A61K; A61K38/00
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
150 words
A compound which inhibits farnesyl-protein transferase of the formula: ##STR9## wherein: X or Y are independently H 2 or O, provided that at least one of these is H 2 ; R 1 is H, an alkyl group, an acyl group, an alkylsulfonyl group or arylsulfonyl group, wherein alkyl and acyl groups comprise straight chain or branched chain hydrocarbons of 1 to 6 carbon atoms, or in the alternative R 1 NH may be absent; R 2 and R 3 are the side chains of naturally occurring amino acids, or in the alternative may be substituted or unsubstituted aliphatic, aromatic or heterocyclic groups, which comprise allyl, cyclohexyl, phenyl, pyridyl, imidazolyl or saturated chains of 2 to 8 carbon atoms, wherein the aliphatic substitutents may be substituted with an aromatic or heteroaromatic ring; Z is O or S; and n is 0, 1, or 2; or the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim
150 words
A compound which inhibits farnesyl-protein transferase of the formula: ##STR9## wherein: X or Y are independently H 2 or O, provided that at least one of these is H 2 ; R 1 is H, an alkyl group, an acyl group, an alkylsulfonyl group or arylsulfonyl group, wherein alkyl and acyl groups comprise straight chain or branched chain hydrocarbons of 1 to 6 carbon atoms, or in the alternative R 1 NH may be absent; R 2 and R 3 are the side chains of naturally occurring amino acids, or in the alternative may be substituted or unsubstituted aliphatic, aromatic or heterocyclic groups, which comprise allyl, cyclohexyl, phenyl, pyridyl, imidazolyl or saturated chains of 2 to 8 carbon atoms, wherein the aliphatic substitutents may be substituted with an aromatic or heteroaromatic ring; Z is O or S; and n is 0, 1, or 2; or the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim
23 words
A compound which inhibits farnesyl-protein transferase which is: N-(2(R)-amino-3-mercaptopropyl)isoleucyl-phenylalanylhomoserine, N-(2(R)-amino-3-mercaptopropyl)isoleucyl-isoleucyl-homoserine, N-[2(S)-(2(R)-amino-3-mercaptopropylamino)-3(S)-methyl pentyl]isoleucyl-homoserine, N-[N'-(2(R)-amino-3-mercaptopropyl)isoleucyl-phenyl-alanyl]-3(S)-amino-4-hydroxypentanoic acid, or N-[N'-(2(R)-amino-3-mercaptopropyl)isoleucyl-isoleucyl]-3(S)-amino-4-hydroxypentanoic acid, or the pharmaceutically acceptable salts thereof.
Claim 4
Dependent Claim
23 words
A compound which inhibits farnesyl-protein transferase which is: N-(2(R)-amino-3-mercaptopropyl)isoleucyl-phenylalanylhomoserine, N-(2(R)-amino-3-mercaptopropyl)isoleucyl-isoleucyl-homoserine, N-[2(S)-(2(R)-amino-3-mercaptopropylamino)-3(S)-methyl pentyl]isoleucyl-homoserine, N-[N'-(2(R)-amino-3-mercaptopropyl)isoleucyl-phenyl-alanyl]-3(S)-amino-4-hydroxypentanoic acid, or N-[N'-(2(R)-amino-3-mercaptopropyl)isoleucyl-isoleucyl]-3(S)-amino-4-hydroxypentanoic acid, or the pharmaceutically acceptable salts thereof.
Claim 5
Dependent Claim
10 words
A compound of claim 2 which is: N-[2(S)-(2(R)-amino-3-mercaptopropylamino)-3(S)-methyl pentyl]isoleucyl-homoserine ##STR10##
Claim 6
Dependent Claim
9 words
A compound of claim 2 is: N-[N'-(2(R)-amino-3-mercaptopropyl)isoleucyl-isoleucyl]-3(S)-amino-4-hydroxy-pentanoic acid ##STR11##
Claim 7
Dependent Claim
20 words
A pharmaceutical composition comprising a pharmaceutical carrier, and dispersed therein, a therapeutically effective amount of a compound of claim 1.
Claim 8
Dependent Claim
19 words
A pharmaceutical composition comprising a pharmaceutical carrier, and dispersed therein, a therapeutically effective amount of compound of claim 2.
Claim 9
Dependent Claim
19 words
A pharmaceutical composition comprising a pharmaceutical carrier, and dispersed therein, a therapeutically effective amount of compound of claim 3.
Claim 10
Dependent Claim
19 words
A pharmaceutical composition comprising a pharmaceutical carrier, and dispersed therein, a therapeutically effective amount of compound of claim 4.
References Cited (Backward Citations)
US4931591A
Cited
US4855286A
Cited
US4801609B1
Cited
US4801609A
Cited
EP0322184A2
Cited
US4977277A
Cited
US4929641A
Cited
US4929641B1
Cited
US4879309A
Cited
US4879309B1
Cited
US5081284A
Cited
WO1991016340A1
Cited
US5043268A
Cited
EP0456180A1
Cited
EP0461869A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-08-22 | 1998-02-21 | 1998-08-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-08-22 | 2002-02-21 | 2002-08-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-08-22 | 2006-02-21 | 2006-08-23 | $7700.00 | Window Closed / Lapsed |